| Pediatric Critical Care and COVID-19 #MMPMID32518171Gonzalez-Dambrauskas S; Vasquez-Hoyos P; Camporesi A; Diaz-Rubio F; Pineres-Olave BE; Fernandez-Sarmiento J; Gertz S; Harwayne-Gidansky I; Pietroboni P; Shein SL; Urbano J; Wegner A; Zemanate E; Karsies TPediatrics 2020[Sep]; 146 (3): ä PMID32518171show ga
ä|*Global Health[MESH]|Adolescent[MESH]|COVID-19[MESH]|Child[MESH]|Child, Preschool[MESH]|Chile[MESH]|Cohort Studies[MESH]|Colombia[MESH]|Combined Modality Therapy[MESH]|Coronavirus Infections/diagnosis/epidemiology/*therapy[MESH]|Critical Care/*organization & administration[MESH]|Critical Illness/mortality/therapy[MESH]|Drug Therapy, Combination[MESH]|Female[MESH]|Hospital Mortality[MESH]|Humans[MESH]|Intensive Care Units, Pediatric/*organization & administration[MESH]|Internationality[MESH]|Italy[MESH]|Male[MESH]|Pandemics/*statistics & numerical data[MESH]|Pediatrics/organization & administration[MESH]|Pneumonia, Viral/diagnosis/epidemiology/*therapy[MESH]|Respiration, Artificial/methods[MESH]|Retrospective Studies[MESH]|Risk Assessment[MESH]|Severe Acute Respiratory Syndrome/diagnosis/mortality/*therapy[MESH]|Spain[MESH]
DeepDyve Pubget Overpricing |
|